The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders
Open accessAbstract
Insulin resistance and other risk factors for atherosclerosis, such as hypertension and hypercholesterolemia, promote endothelial dysfunction and lead to development of metabolic syndrome which constitutes an introduction to cardiovascular disease. The insulin resistance and endothelial dysfunction cross talk between each other by numerous metabolic pathways. Hence, targeting one of these pathologies with pleiotropic treatment exerts beneficial effect on another one. Combined and expletive treatment of hypertension, lipid disorders, and insulin resistance with nonpharmacological interventions and conventional pharmacotherapy may inhibit the transformation of metabolic disturbances to fully developed cardiovascular disease. This paper summarises the common therapeutic targets for insulin resistance, endothelial dysfunction, and vascular inflammatory reaction at molecular level and analyses the potential pleiotropic effects of drugs used currently in management of cardiovascular disease, metabolic syndrome, and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
NF-κB, Inflammation, and Metabolic Disease
Baker, R. G., Hayden, M. S., & Ghosh, S. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.008 · Cited by 1,952
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Sofi, F., Abbate, R., Gensini, G. F., & Casini, A. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29673 · Cited by 1,605
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139
Lawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,071
Mancini, G. B. J., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H., Lu¨scher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,057
Hemmings, B. A., & Restuccia, D. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011189 · Cited by 1,049
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Effect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferrucci, L., Striker, G., & Vlassara, H. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.4.427 · Cited by 570
Arakawa, M., Mita, T., Azuma, K., Ebato, C., Goto, H., Nomiyama, T., Fujitani, Y., Hirose, T., Kawamori, R., & Watada, H. (2010) · Diabetes · doi:10.2337/db09-1694 · Cited by 548
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., & Michel, J.-B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 517
Davis, B. J., Xie, Z., Viollet, B., & Zou, M.-H. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1064 · Cited by 467
Endothelial Dysfunction in Diabetes
Avogaro, A., Albiero, M., Menegazzo, L., de Kreutzenberg, S., & Fadini, G. P. (2011) · Diabetes Care · doi:10.2337/dc11-s239 · Cited by 465
The ERK Cascade: A Prototype of MAPK Signaling
Rubinfeld, H., & Seger, R. (2005) · Molecular Biotechnology · doi:10.1385/mb:31:2:151 · Cited by 460
Nagueh, S. F., Lakkis, N. M., Middleton, K. J., Franklin, J., & Spencer, W. H. (2004) · Circulation · doi:10.1161/01.cir.0000115644.35804.8b · Cited by 425
McCabe, T. J., Fulton, D., Roman, L. J., & Sessa, W. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6123 · Cited by 387 · cited 1×
“The eNOS activation is mediated by inhibition of calmodulin dissociation and electron transfer in a reductase domain [17].”
BackgroundNatali, A., & Ferrannini, E. (2006) · Diabetologia · doi:10.1007/s00125-006-0141-7 · Cited by 377
Shah, Z., Kampfrath, T., Deiuliis, J. A., Zhong, J., Pineda, C., Ying, Z., Xu, X., Lu, B., Moffatt-Bruce, S., Durairaj, R., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.041418 · Cited by 377
Tissue–Specific Insulin Signaling, Metabolic Syndrome, and Cardiovascular Disease
Rask-Madsen, C., & Kahn, C. R. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241919 · Cited by 375
Montagnani, M., Golovchenko, I., Kim, I., Koh, G. Y., Goalstone, M. L., Mundhekar, A. N., Johansen, M., Kucik, D. F., Quon, M. J., & Draznin, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103728200 · Cited by 330
Rizza, S., Muniyappa, R., Iantorno, M., Kim, J.-A., Chen, H., Pullikotil, P., Senese, N., Tesauro, M., Lauro, D., Cardillo, C., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2879 · Cited by 324
Insulin-Like Signaling, Nutrient Homeostasis, and Life Span
Taguchi, A., & White, M. F. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100533 · Cited by 310
Chelating Activity of Advanced Glycation End-product Inhibitors
Price, D. L., Rhett, P. M., Thorpe, S. R., & Baynes, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108196200 · Cited by 308
Koh, K. K., Quon, M. J., Han, S. H., Chung, W.-J., Ahn, J. Y., Seo, Y.-H., Kang, M. H., Ahn, T. H., Choi, I. S., & Shin, E. K. (2004) · Circulation · doi:10.1161/01.cir.0000143085.86697.13 · Cited by 279
Role of endothelial dysfunction in insulin resistance
Hsueh, W. A., & Quiñones, M. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00611-8 · Cited by 276
The endothelium and vascular inflammation in diabetes
Hartge, M. M., Unger, T., & Kintscher, U. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.025 · Cited by 267
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
Scheen, A. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70146-5 · Cited by 252
Koloverou, E., Esposito, K., Giugliano, D., & Panagiotakos, D. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.010 · Cited by 250
Advanced glycation end products, their receptors and diabetic angiopathy.
Wautier, J., & Guillausseau, P.-J. (2001) · PubMed · Cited by 232
Musicki, B., Kramer, M. F., Becker, R. E., & Burnett, A. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502488102 · Cited by 229
Dicker, D. (2011) · Diabetes Care · doi:10.2337/dc11-s229 · Cited by 229
Erdogdu, Ö., Nathanson, D., Sjöholm, Å., Nyström, T., & Zhang, Q. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.022 · Cited by 229
Hermann, C., Assmus, B., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.402 · Cited by 228
Manrique, C., Lastra, G., Gardner, M., & Sowers, J. R. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.014 · Cited by 224
Regulation of insulin receptor function
Youngren, J. F. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6359-9 · Cited by 223
Zheng, X.-X., Xu, Y.-L., Li, S.-H., Liu, X.-X., Hui, R., & Huang, X.-H. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.010926 · Cited by 212
Esposito, K., Maiorino, M. I., Petrizzo, M., Bellastella, G., & Giugliano, D. (2014) · Diabetes Care · doi:10.2337/dc13-2899 · Cited by 205 · cited 1×
“by comparing Mediterranean to low-fat diet with an effect of remission of diabetes and delay of drug requirement [61].”
Ferri, C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.3.829 · Cited by 205
Insulin signaling in the arterial wall
Hsueh, W. A., & Law, R. E. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00353-7 · Cited by 200
Del Prato, S. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02847.x · Cited by 197
Role of Nitric Oxide in the Modulation of Angiogenesis
Morbidelli, L., Donnini, S., & Ziche, M. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033391405 · Cited by 192
PPARγ and Atherosclerosis: Effects on Cell Growth and Movement
Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100261 · Cited by 191
Advanced glycation end products, their receptors and diabetic angiopathy
Wautier, J., & Guillausseau, P. (2002) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2002.02011_16.x · Cited by 188
Pentosidine: A molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia
Sell, D. R., Nagaraj, R. H., Grandhee, S. K., Odetti, P., Lapolla, A., Fogarty, J., & Monnier, V. M. (1991) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610070404 · Cited by 187
Liu, H., Dear, A. E., Knudsen, L. B., & Simpson, R. W. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0468 · Cited by 187
Kassan, M., Galan, M., Partyka, M., Trebak, M., & Matrougui, K. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.233262 · Cited by 176
Polikandriotis, J. A., Mazzella, L. J., Rupnow, H. L., & Hart, C. M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000177805.65864.d4 · Cited by 169
Dynamics of Insulin Signaling in 3T3-L1 Adipocytes
Inoue, G., Cheatham, B., Emkey, R., & Kahn, C. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11548 · Cited by 168
Hadjiyanni, I., Siminovitch, K. A., Danska, J. S., & Drucker, D. J. (2010) · Diabetologia · doi:10.1007/s00125-009-1643-x · Cited by 166
Bouchonville, M., Armamento-Villareal, R., Shah, K., Napoli, N., Sinacore, D. R., Qualls, C., & Villareal, D. T. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.122 · Cited by 163
Kellow, N. J., & Savige, G. S. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.220 · Cited by 162
Mathew, M., Tay, E., & Cusi, K. J. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-9 · Cited by 147
Miao, B., Skidan, I. N., Yang, J., Lugovskoy, A. A., Reibarkh, M., Long, K., Brazell, T., Durugkar, K. A., Maki, J. L., Ramana, C. V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004522107 · Cited by 138
Effect of advanced glycation end product intake on inflammation and aging: a systematic review
Puyvelde, K. V., Mets, T. F., Njemini, R., Beyer, I., & Bautmans, I. (2014) · Nutrition Reviews · doi:10.1111/nure.12141 · Cited by 129
Insulin Action in the Vasculature: Physiology and Pathophysiology
Mather, K. J., Anderson, T. J., & Verma, S. (2001) · Journal of Vascular Research · doi:10.1159/000051074 · Cited by 123
Hançer, N. J., Qiu, W., Cherella, C. E., Li, Y., Copps, K. D., & White, M. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554162 · Cited by 123
Economides, P. A., Caselli, A., Tiani, E., Khaodhiar, L., Horton, E. S., & Veves, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031116 · Cited by 120
Munir, K. M., Chandrasekaran, S., Gao, F., & Quon, M. J. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00377.2013 · Cited by 110
Mechanisms of Lipotoxicity in the Cardiovascular System
Wende, A. R., Symons, J. D., & Abel, E. D. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0307-2 · Cited by 110
Giraud, J., Leshan, R. L., Lee, Y.-H., & White, M. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308631200 · Cited by 104
Aroor, A. R., Sowers, J. R., Bender, S. B., Nistala, R., Garro, M., Mugerfeld, I., Hayden, M. R., Johnson, M. S., Salam, M., Whaley‐Connell, A. T., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1096 · Cited by 102
Tocci, G., Paneni, F., Palano, F., Sciarretta, S., Ferrucci, A., Kurtz, T. W., Mancia, G., & Volpe, M. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.8 · Cited by 88
Li, H., Li, H., Bao, Y., Zhang, X., & Yu, Y. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.07.019 · Cited by 86
Kaplan, M., Aviram, M., & Hayek, T. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.002 · Cited by 80
Gage, M., Yuldasheva, N. Y., Viswambharan, H., Sukumar, P., Cubbon, R. M., Galloway, S. L., Imrie, H., Skromna, A., Smith, J., Jackson, C. L., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.017 · Cited by 75
Gabriely, I., Yang, X. M., Cases, J. A., Xiao, H., Rossetti, L., & Barzilai, N. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00574-3 · Cited by 62
Suksomboon, N., Poolsup, N., & Prasit, T. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01295.x · Cited by 58
Antidiabetic Agents and Endothelial Dysfunction – Beyond Glucose Control
Eriksson, L., & Nyström, T. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12402 · Cited by 52
The renin–angiotensin–aldosterone system: a pivotal role in insulin sensitivity and glycemic control
Perkins, J. M., & Davis, S. N. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f7026f · Cited by 51
Berg, G. A., Schreier, L. E., & Miksztowicz, V. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0069 · Cited by 40
Stimulation of Urinary TGF-β and Isoprostanes in Response to Hyperglycemia in Humans
McGowan, T., Dunn, S., Falkner, B. E., & Sharma, K. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00990905 · Cited by 36
Jung, K. H., Choi, H. S., Kim, D. H., Han, M. Y., Chang, U. J., Yim, S., Song, B. C., Kim, C., & Kang, S. A. (2008) · Journal of Medicinal Food · doi:10.1089/jmf.2007.0107 · Cited by 31
Insulin Sensitization Therapy and the Heart
Wong, A., Struthers, A. D., Choy, A. M., & Lang, C. C. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.002 · Cited by 18
Vessels vivified by Akt acting on NO synthase
Snyder, S. H., & Jaffrey, S. R. (1999) · Nature Cell Biology · doi:10.1038/12093 · Cited by 14
Cited by
Association between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Yang, D.-R., Wang, M.-Y., Zhang, C.-L., & Wang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359255 · Cited by 280
Barzegar, N., Tohidi, M., Hasheminia, M., Azizi, F., & Hadaegh, F. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01121-5 · Cited by 261
Huang, J.-P., Hsu, S.-C., Li, D.-E., Chen, K.-H., Kuo, C.-Y., & Hung, L.-M. (2018) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000621 · Cited by 33
Metadata
- Authors
- Janus, A., Szahidewicz-Krupska, E., Mazur, G., & Doroszko, A.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-10
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- OpenAlex
- W2441693614
- Cited by
- 271
- References
- 92
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.